United Therapeutics Corp (UTHR)

190.66 -1.61  -0.84% NASDAQ Oct 21, 16:00 190.76 +0.10  +0.05% After-Hours: 20:00 USD
View Full Chart
Price Chart
View All UTHR News

News

View All Events

Events

Date Type Description
10/28/2021 Earnings Results Q3 2021 Earnings Results
10/28/2021 09:00 EST Earnings Calls Q3 2021 Earnings Call
08/04/2021 Earnings Results Q2 2021 Earnings Results
08/04/2021 09:00 EST Earnings Calls Q2 2021 Earnings Call
06/25/2021 AGM 2021 Annual General Meeting
05/05/2021 Earnings Results Q1 2021 Earnings Results
05/05/2021 09:00 EST Earnings Calls Q1 2021 Earnings Call
02/24/2021 Earnings Results Q4 2020 Earnings Results
02/24/2021 09:00 EST Earnings Calls Q4 2020 Earnings Call
10/28/2020 Earnings Results Q3 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for pulmonary arterial hypertension largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. Nearly all of its sales are generated within the United States. United also markets a pediatric oncology drug, but its focus largely remains in pulmonary hypertension.
  • URL: https://www.unither.com
  • Investor Relations URL: https://ir.unither.com/
  • HQ State/Province: Maryland
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Mid Cap/Value
  • Next Earnings Release: Oct. 28, 2021
  • Last Earnings Release: Aug. 04, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
PJP Invesco Dynamic Pharmaceuticals ETF 3.62%
FBT First Trust NYSE Arca Biotech ETF 3.44%
FTHAX Fuller & Thaler Behavioral Sm-Cp Eq A 2.59%
FDMLX Fidelity® Series Intrinsic Opps 1.88%
FXH First Trust Health Care AlphaDEX® ETF 1.63%
DLRHX Delaware Healthcare R 1.52%
HSPCX Emerald Growth C 1.42%
TRVHX TIAA-CREF Mid-Cap Value Advisor 1.37%
HQH Tekla Healthcare Investors 1.09%
SMMV iShares MSCI USA Sm-Cp Min Vol Fctr ETF 1.06%
SMLF iShares MSCI USA Small-Cap Mltfctr ETF 0.84%
FID6027 Fidelity Global Intrinsic Value Cl P4T5 0.76%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.